| 1 |
Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations [J]. J Clin Epidemiol, 2013, 66:719-725.
|
| 2 |
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review [J]. Gut, 2014, 63:871-880.
|
| 3 |
Mauritz FA, van Herwaarden-Lindeboom MY, Stomp W, et al. The effects and efficacy of antireflux surgery in children with gastroesophageal reflux disease: a systematic review [J]. J Gastrointest Surg, 2011, 15:1872-1878.
|
| 4 |
Martigne L, Delaage PH, Thomas-Delecourt F, et al. Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study [J]. Eur J Pediatr, 2012, 171:1767-1773.
|
| 5 |
Wileman SM, McCann S, Grant AM, et al. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults [J]. Cochrane Database Syst Rev, 2010, 2010:Cd003243.
|
| 6 |
Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction [J]. BMJ, 2016, 353:i2016.
|
| 7 |
Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines [J]. BMJ, 2016, 353:i2089.
|
| 8 |
Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength [J]. J Clin Epidemiol, 2013, 66:726-735.
|
| 9 |
GRADEpro GDT: GRADEpro Guideline Development Tool [EB/OL]. (2020-12-30).
URL
|
| 10 |
Chen Y, Yang K, Marusic A, et al. A Reporting tool for practice guidelines in health care: the RIGHT statement [J]. Ann Intern Med, 2017, 166:128-132.
|
| 11 |
McKinley SK, Dirks RC, Walsh D, et al. Surgical treatment of GERD: systematic review and meta-analysis [J]. Surg Endosc, 2021, 35(1):1-29.
|
| 12 |
Schünemann H, Brożek J, Guyatt G, et al. GRADE handbook for grading quality of evidence and strength of recommendations [EB/OL]. (2021-01-10).
URL
|
| 13 |
Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity [J]. Ann Surg, 2013, 258:1-7.
|
| 14 |
Esposito C, Montupet P, van Der Zee D, et al. Long-term outcome of laparoscopic Nissen, Toupet, and Thal antireflux procedures for neurologically normal children with gastroesophageal reflux disease [J]. Surg Endosc, 2006, 20:855-858.
|
| 15 |
Wang YH, Wintzell V, Ludvigsson JF, et al. Association between proton pump inhibitor use and risk of fracture in children [J]. JAMA Pediatr, 2020, 174:543-551.
|
| 16 |
Villamanan E, Ruano M, Lara C, et al. Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care [J]. Rev Esp Enferm Dig, 2015, 107:652-658.
|
| 17 |
Januszewicz W, Hartley J, Waldock W, et al. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease [J]. United Eur Gastroenterol J, 2019, 7:1389-1398.
|
| 18 |
Albassam AA, Mallick MS, Gado A, et al. Nissen fundoplication, robotic-assisted versus laparoscopic procedure: a comparative study in children [J]. Eur J Pediatr Surg, 2009, 19:316-319.
|
| 19 |
Anderberg M, Kockum CC, Arnbjornsson E. Robotic fundoplication in children [J]. Pediatr Surg Int, 2007, 23:123-127.
|
| 20 |
Copeland DR, Boneti C, Kokoska ER, et al. Evaluation of initial experience and comparison of the da Vinci surgical system with established laparoscopic and open pediatric Nissen fundoplication surgery [J]. JSLS, 2008, 12:238-240.
|
| 21 |
Lehnert M, Richter B, Beyer PA, et al. A prospective study comparing operative time in conventional laparoscopic and robotically assisted Thal semifundoplication in children [J]. J Pediatr Surg, 2006, 41:1392-1396.
|
| 22 |
Muller-Stich BP, Reiter MA, Mehrabi A, et al. No relevant difference in quality of life and functional outcome at 12 months' follow-up-a randomised controlled trial comparing robot-assisted versus conventional laparoscopic Nissen fundoplication [J]. Langenbecks Arch Surg, 2009, 394:441-446.
|
| 23 |
Higgins RM, Frelich MJ, Bosler ME, et al. Cost analysis of robotic versus laparoscopic general surgery procedures [J]. Surg Endosc, 2017, 31:185-192.
|
| 24 |
Watson DI, Pike GK, Baigrie RJ, et al. Prospective double-blind randomized trial of laparoscopic Nissen fundoplication with division and without division of short gastric vessels [J]. Ann Surg, 1997, 226:642-652.
|
| 25 |
O'Boyle CJ, Watson DI, Jamieson GG, et al. Division of short gastric vessels at laparoscopic nissen fundoplication: a prospective double-blind randomized trial with 5-year follow-up [J]. Ann Surg, 2002, 235:165-170.
|
| 26 |
Kinsey-Trotman SP, Devitt PG, et al. Randomized trial of division versus nondivision of short gastric vessels during nissen fundoplication: 20-year outcomes [J]. Ann Surg, 2018, 268:228-232.
|
| 27 |
St Peter SD, Barnhart DC, Ostlie DJ, et al. Minimal vs extensive esophageal mobilization during laparoscopic fundoplication: a prospective randomized trial [J]. J Pediatr Surg, 2011, 46:163-168.
|
| 28 |
Yadlapati R, Vaezi MF, Vela MF, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel [J]. Am J Gastroenterol, 2018, 113:980-986.
|
| 29 |
Wiens E, Kovaltchouk U, Koomson A, et al. The clinician's guide to proton-pump inhibitor discontinuation [J]. J Clin Gastroenterol, 2019, 53:553-559.
|
| 30 |
Surdea-Blaga T, Băncilă I, Dobru D, et al. Mucosal protective compounds in the treatment of gastroesophageal reflux disease. a position paper based on evidence of the romanian society of neurogastroenterology [J]. J Gastrointestin Liver Dis, 2016, 25:537-546.
|
| 31 |
Stefanidis D, Hope WW, Kohn GP, et al. Guidelines for surgical treatment of gastroesophageal reflux disease [J]. Surg Endosc, 2010, 24:2647-2669.
|
| 32 |
Shaheen NJ, Weinberg DS, Denberg TD, et al. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians [J]. Ann Intern Med, 2012, 157:808-816.
|
| 33 |
Seo HS, Choi M, Son SY, et al. Evidence-based practice guideline for surgical treatment of gastroesophageal reflux disease 2018 [J]. J Gastric Cancer, 2018, 18:313-327.
|
| 34 |
Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the north american society for pediatric gastroenterology, hepatology, and nutrition and the european society for pediatric gastroenterology, hepatology, and nutrition [J]. J Pediatr Gastroenterol Nutr, 2018, 66:516-554.
|
| 35 |
Richter JE, Pandolfino JE, Vela MF, et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group [J]. Dis Esophagus, 2013, 26:755-765.
|
| 36 |
Randel A. AAP releases guideline for the management of gastroesophageal reflux in children [J]. Am Fam Physician, 2014, 89:395-397.
|
| 37 |
Patti MG, Vela MF, Odell DD, et al. The intersection of GERD, aspiration, and lung transplantation [J]. J Laparoendosc Adv Surg Tech A, 2016, 26:501-505.
|
| 38 |
Muthusamy VR, Lightdale JR, Acosta RD, et al. The role of endoscopy in the management of GERD. Gastrointest Endosc, 2015, 81:1305-1310.
|
| 39 |
Kahrilas PJ, Altman KW, Chang AB, et al. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report [J]. Chest, 2016, 150:1341-1360.
|
| 40 |
Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015 [J]. J Gastroenterol, 2016, 51:751-767.
|
| 41 |
Hunt R, Armstrong D, Katelaris P, et al. World gastroenterology organisation global guidelines: GERD global perspective on gastroesophageal reflux disease [J]. J Clin Gastroenterol, 2017, 51:467-478.
|
| 42 |
Huerta-Iga F, Tamayo-de la Cuesta JL, Noble-Lugo A, et al. The Mexican consensus on gastroesophageal reflux disease. Part Ⅱ [J]. Rev Gastroenterol Mex, 2013, 78:231-239.
|
| 43 |
Huerta-Iga F, Bielsa-Fernández MV, Remes-Troche JM, et al. Diagnosis and treatment of gastroesophageal reflux disease: recommendations of the Asociación Mexicana de Gastroenterología [J]. Rev Gastroenterol Mex, 2016, 81:208-222.
|
| 44 |
Fuchs KH, Babic B, Breithaupt W, et al. EAES recommendations for the management of gastroesophageal reflux disease [J]. Surg Endosc, 2014, 28:1753-1773.
|
| 45 |
Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus [J]. Gut, 2016, 65:1402-1415.
|
| 46 |
Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline [J]. Can Fam Physician, 2017, 63:354-364.
|
| 47 |
Davies I, Burman-Roy S, Murphy MS. Gastro-oesophageal reflux disease in children: NICE guidance. BMJ, 2015, 350:g7703.
|
| 48 |
Indonesian Society of Gastroenterology. National consensus on the management of gastroesophageal reflux disease in Indonesia [J]. Acta Med Indones, 2014, 46:263-271.
|
| 49 |
Rickenbacher N, Kötter T, Kochen MM, et al. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis [J]. Surg Endosc, 2014, 28:143-155.
|